GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zafgen Inc (NAS:ZFGN) » Definitions » Other Long Term Assets

Zafgen (Zafgen) Other Long Term Assets : $1.35 Mil (As of Mar. 2020)


View and export this data going back to 2014. Start your Free Trial

What is Zafgen Other Long Term Assets?

Zafgen's other long-term assets for the quarter that ended in Mar. 2020 was $1.35 Mil.

Zafgen's quarterly other long-term assets declined from Sep. 2019 ($1.36 Mil) to Dec. 2019 ($1.36 Mil) but then stayed the same from Dec. 2019 ($1.36 Mil) to Mar. 2020 ($1.35 Mil).

Zafgen's annual other long-term assets declined from Dec. 2017 ($0.06 Mil) to Dec. 2018 ($0.06 Mil) but then increased from Dec. 2018 ($0.06 Mil) to Dec. 2019 ($1.36 Mil).


Zafgen Other Long Term Assets Historical Data

The historical data trend for Zafgen's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zafgen Other Long Term Assets Chart

Zafgen Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only 0.09 0.06 0.06 0.06 1.36

Zafgen Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.49 1.57 1.36 1.36 1.35

Zafgen Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Zafgen (Zafgen) Business Description

Traded in Other Exchanges
N/A
Address
3 Center Plaza, Suite 610, Boston, MA, USA, 02108
Zafgen Inc is a US-based biopharmaceutical company. It focuses on developing novel therapeutics that treat the underlying biological mechanisms through the methionine aminopeptidase 2, or MetAP2, pathway. The lead product candidate of the company is ZGN-1061 which is a novel fumagillin-class MetAP2 inhibitor administered by subcutaneous injection. The company operates in the business of developing novel therapeutics. The company primarily carries its business operations in the United States.